Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangdan Wang

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The AAPS Journal|October 1, 2025
A Fit-for-purpose Strategy for Clinical Immunogenicity Assessment of Multivalent Bispecific AntibodiesZhaojun Yin, Bob Y Liu, Ben Ordonia, et al.
Bioconjugate Chemistry|December 5, 2023
Application of N-Terminal Site-Specific Biotin and Digoxigenin Conjugates to Clinical Anti-drug Antibody Assay DevelopmentXiangdan Wang, Wenping Chang, Mehraban Khosraviani, et al.
Arthritis and Rheumatism|April 21, 2011
Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosusAlyssa M Morimoto, Donna Thibault Flesher, Jihong Yang, et al.
The AAPS Journal|January 5, 2020
The Production, Quality Control, and Characterization of ZED8, a CD8-Specific <sup>89</sup>Zr-Labeled Immuno-PET Clinical Imaging AgentHerman Gill, Richard Seipert, Vincent M Carroll, et al.
Nature Communications|May 2, 2024
HPK1 citron homology domain regulates phosphorylation of SLP76 and modulates kinase domain interaction dynamicsAvantika S Chitre, Ping Wu, Benjamin T Walters, et al.
Mabs|June 19, 2013
Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgGXiangdan Wang, Valerie Quarmby, Carl Ng, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2014
Complement inhibition in cynomolgus monkeys by anti-factor d antigen-binding fragment for the treatment of an advanced form of dry age-related macular degenerationKelly M Loyet, Jeremy Good, Teresa Davancaze, et al.
Mabs|September 7, 2010
Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in ratsLeslie A Khawli, Sirj Goswami, Ryan Hutchinson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2022
Preclinical development of ZED8, an <sup>89</sup>Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapyAnnie Ogasawara, James R Kiefer, Herman Gill, et al.
Ebiomedicine|July 6, 2025
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsJérémie Decalf, Evangeline Toy, Dongping He, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The AAPS Journal|October 1, 2025
A Fit-for-purpose Strategy for Clinical Immunogenicity Assessment of Multivalent Bispecific AntibodiesZhaojun Yin, Bob Y Liu, Ben Ordonia, et al.
Bioconjugate Chemistry|December 5, 2023
Application of N-Terminal Site-Specific Biotin and Digoxigenin Conjugates to Clinical Anti-drug Antibody Assay DevelopmentXiangdan Wang, Wenping Chang, Mehraban Khosraviani, et al.
Arthritis and Rheumatism|April 21, 2011
Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosusAlyssa M Morimoto, Donna Thibault Flesher, Jihong Yang, et al.
The AAPS Journal|January 5, 2020
The Production, Quality Control, and Characterization of ZED8, a CD8-Specific <sup>89</sup>Zr-Labeled Immuno-PET Clinical Imaging AgentHerman Gill, Richard Seipert, Vincent M Carroll, et al.
Nature Communications|May 2, 2024
HPK1 citron homology domain regulates phosphorylation of SLP76 and modulates kinase domain interaction dynamicsAvantika S Chitre, Ping Wu, Benjamin T Walters, et al.
Mabs|June 19, 2013
Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgGXiangdan Wang, Valerie Quarmby, Carl Ng, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2014
Complement inhibition in cynomolgus monkeys by anti-factor d antigen-binding fragment for the treatment of an advanced form of dry age-related macular degenerationKelly M Loyet, Jeremy Good, Teresa Davancaze, et al.
Mabs|September 7, 2010
Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in ratsLeslie A Khawli, Sirj Goswami, Ryan Hutchinson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2022
Preclinical development of ZED8, an <sup>89</sup>Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapyAnnie Ogasawara, James R Kiefer, Herman Gill, et al.
Ebiomedicine|July 6, 2025
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsJérémie Decalf, Evangeline Toy, Dongping He, et al.
Pageof 2